Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis
Jt. Holbrook et al., Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis, CONTR CL TR, 22(1), 2001, pp. 62-68
We reviewed procedures for and data about patient notification of the suspe
nsion of the treatment protocol for four clinical trials. We also examined
how data collected after the suspensions were used. All four trials were de
signed to evaluate treatments for cytomegalovirus retinitis in patients wit
h AIDS and were conducted by the Studies of Ocular Complications of AIDS Re
search Group. Documentation that patients were notified of the results vari
ed from 62-100% with three of the four studies documenting the process for
greater than or equal to 92% of patients. The median time between the recom
mendation for protocol suspension and patient notification varied from 7-49
days with three of the four trials at 12 days or fewer. Most of the analys
es of data collected after the suspension of the treatment protocol did not
focus on comparisons among treatment groups. Although they provided useful
information about the long-term outcomes and the nature of the disease, th
ey did not alter the conclusions about safety and efficacy from the randomi
zed portion of the trial. (C) Elsevier Science Inc. 2001.